---  
layout: startup_page  
title: "Ability Biologics"  
id: "ability.bio"  
permalink: "/abilitybiologicsability.bio06182024/"  
website: "https://www.ability.bio/"  
funding_round: "Seed"  
funding_amount: "$18M"  
investors: "Amplitude Ventures, Fonds de solidarité FTQ, Investissement Québec, Charles River Laboratories, Theodorus, Alexandria Venture Investments"  
about: "Ability Biologics uses generative AI to discover and develop potent and selective antibody therapeutics for cancer and immune-related disorders. Its AbiLeap discovery engine generates novel antibodies with the potential to be best-in-class or first-in-class therapeutics by targeting specific tissues and cells based on the local microenvironment. This approach addresses limitations of traditional antibody therapies."  
markets: "Biotechnology, AI, Therapeutics, Antibody Discovery, Life Science, Drug Discovery, Oncology"  
hq: "Montreal, Quebec, Canada"  
founded_year: "2023"  
linkedin: "https://www.linkedin.com/company/ability-biologics/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ability-biologics"  
pitchbook: "https://pitchbook.com/profiles/company/541502-65"  

date_display: "18-Jun-2024"  
date: "2024-06-18"

# SEO Optimization  
meta_title: "Ability Biologics - Seed Funding ($18M)"  
meta_description: "Ability Biologics, Ability Biologics uses generative AI to discover and develop potent and selective antibody therapeutics for cancer and immune-related disorders. Its A..."  
meta_keywords: "Ability Biologics, Biotechnology, AI, Therapeutics, Antibody Discovery, Life Science, Drug Discovery, Oncology, Seed funding"  
canonical_url: "https://startup.projectstartups.com/abilitybiologicsability.bio06182024/"  
---